Advertisement

Topics

US Combo Product Designation Appeal Process Limited In Proposed Rule

20:28 EDT 17 May 2018 | SCRIP

Overhaul of reg on how combo products are designated to review centers eliminates the reconsideration appeal, but US FDA still...

      

Related Stories

 

Original Article: US Combo Product Designation Appeal Process Limited In Proposed Rule

NEXT ARTICLE

More From BioPortfolio on "US Combo Product Designation Appeal Process Limited In Proposed Rule"

Advertisement
Quick Search
Advertisement
Advertisement